The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The PARSC trial, a prospective study for the assessment of recurrence risk in stage II colon cancer (CC) patients using ColoPrint.
R. Salazar
No relevant relationships to disclose
R. Rosenberg
No relevant relationships to disclose
M. Lutke Holzik
No relevant relationships to disclose
J. Marshall
No relevant relationships to disclose
J. J. M. Van Der Hoeven
No relevant relationships to disclose
B. Glimelius
No relevant relationships to disclose
F. Bibeau
No relevant relationships to disclose
L. Stork-Sloots
Employment or Leadership Position - Agendia
R. A. Bender
Employment or Leadership Position - Agendia
J. Capdevila
No relevant relationships to disclose